Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2002

View Archived Issues

A crossover study provides evidence of the analgesic properties of reboxetine

NC-1900 improves place learning deficits in rats after transient forebrain ischemia

Fumagillin is effective against intestinal microsporidiosis in immunocompromised patients

New PDE4 inhibitors in early development at Merck KGaA

New ERbeta modulators and their use in Alzheimer's, anxiety, osteoporosis, etc.

Novel MCH antagonists covered by Schering-Plough patent

Ishihara Sangyo describes new inhibitors of Th1 and/or Th2 cytokine production

New ACAT inhibitors prepared and tested by Pola researchers

Alkermes and Reliant call off merger

Ovation acquires Tranxene and Desoxyn from Abbott

Aphton seeks E.U. clearance for G17DT trial in GERD

Yamanouchi discontinues YM-175

MT-100 provides significant pain relief in difficult-to-treat migraine patients

Antisoma completes enrollment in phase I TheraFab trial

Xcytrin to enter new phase III trial in NSCLC patients

Ortho Tri-Cyclen Lo receives FDA approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.